Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Genz 123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 68.00 | |
25 mg | In stock | $ 126.00 | |
50 mg | In stock | $ 197.00 | |
100 mg | In stock | $ 292.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Genz 123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1. |
Targets&IC50 | GM1:14 nM. |
In vivo | GLPG-1690 was able to cause a sustained reduction of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid. |
Molecular Weight | 418.57 |
Formula | C24H38N2O4 |
CAS No. | 491833-30-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (119.45 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Genz-123346 free base 491833-30-8 Metabolism Glucokinase Inhibitor Genz 123346 free base Genz123346 free base Genz 123346 inhibit Genz123346 Genz-123346 inhibitor